microRNA-182-5p alleviates spinal cord injury by inhibiting inflammation and apoptosis through modulating the

Junfeng Zhang1, Yaochi Wu1

  • 1Department of Acupuncture, Tuina, Traumatology, The Sixth People's Hospital Affiliated to Shanghai Jiaotong University Shanghai 200233, China.

Insights

MicroRNA-182-5p significantly reduces inflammation and apoptosis in spinal cord injury models. This microRNA targets Toll-like receptor 4, offering potential therapeutic strategies for spinal cord injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Spinal cord injury (SCI) involves inflammation and apoptosis.
  • MicroRNAs (miRNAs) are implicated as key regulators in SCI.
  • The role of miRNAs in mediating SCI-related inflammation remains unclear.

Purpose of the Study:

  • To investigate the role of miRNAs in SCI.
  • To elucidate the molecular mechanisms by which miRNAs regulate inflammation and apoptosis after SCI.
  • To evaluate miR-182-5p as a potential therapeutic target for SCI.

Main Methods:

  • MicroRNA expression profiling in rat SCI models using miRNA microarray.
  • Cellular studies using C8-D1A cells to assess miR-182-5p function in H2O2-induced inflammation and apoptosis.
  • Identification of Toll-like receptor 4 (TLR4) as a direct target of miR-182-5p.
  • Analysis of the TLR4/NF-κB signaling pathway.

Main Results:

  • miR-182-5p was significantly downregulated in SCI.
  • Overexpression of miR-182-5p reduced pro-inflammatory cytokines and apoptosis in H2O2-treated cells.
  • TLR4 was identified as a direct target of miR-182-5p.
  • miR-182-5p inactivated the TLR4/NF-κB pathway by blocking p65 phosphorylation and promoting IκB-α phosphorylation.

Conclusions:

  • miR-182-5p alleviates inflammation and apoptosis in a cellular SCI model by inactivating the TLR4/NF-κB pathway.
  • miR-182-5p demonstrates potential as a therapeutic target for spinal cord injury.